Steven DuBois

The paper engineers high-affinity cross-reactive antibodies with minimal mutations using deep learning and deep mutational scanning.

This paper identifies a synergistic combination of CDK4/6 and PI3K inhibitors that shows strong anti-Ewing sarcoma activity and improved survival in a xenograft model.

This paper uses large language models to extract prognostic histologic features from Ewing sarcoma pathology reports, identifying NSE and S100 as significant biomarkers.